Pediatrix Medical Group, Inc. (NYSE:MD) Stock Holdings Boosted by MetLife Investment Management LLC

Posted by on Mar 2nd, 2023

MetLife Investment Management LLC lifted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 2.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,151 shares of the company’s stock after acquiring an additional 1,040 shares during the quarter. MetLife Investment Management LLC owned 0.05% of Pediatrix Medical Group worth $745,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Pediatrix Medical Group by 2.3% during the 1st quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock worth $224,045,000 after acquiring an additional 212,150 shares in the last quarter. Lazard Asset Management LLC boosted its stake in shares of Pediatrix Medical Group by 24.3% during the 1st quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock worth $76,631,000 after acquiring an additional 637,798 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Pediatrix Medical Group by 5.0% during the 1st quarter. Wellington Management Group LLP now owns 1,857,926 shares of the company’s stock worth $43,624,000 after acquiring an additional 88,359 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Pediatrix Medical Group by 50.9% during the 3rd quarter. Allianz Asset Management GmbH now owns 428,982 shares of the company’s stock worth $7,082,000 after acquiring an additional 144,625 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of Pediatrix Medical Group by 171.0% during the 1st quarter. Renaissance Technologies LLC now owns 325,800 shares of the company’s stock worth $7,650,000 after acquiring an additional 205,600 shares in the last quarter. 95.99% of the stock is owned by institutional investors.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $15.45 on Thursday. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 0.71. Pediatrix Medical Group, Inc. has a 1 year low of $14.40 and a 1 year high of $24.67. The business has a fifty day simple moving average of $15.39 and a 200 day simple moving average of $16.49. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of 19.31, a P/E/G ratio of 2.38 and a beta of 1.73.

Analyst Ratings Changes

A number of analysts have recently issued reports on MD shares. William Blair restated an “outperform” rating on shares of Pediatrix Medical Group in a report on Thursday, November 3rd. Mizuho reduced their target price on Pediatrix Medical Group from $21.00 to $17.00 and set a “neutral” rating for the company in a report on Wednesday, November 16th. SVB Leerink reduced their target price on Pediatrix Medical Group from $20.00 to $16.00 and set a “market perform” rating for the company in a report on Friday, November 4th. Finally, Credit Suisse Group reduced their target price on Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating for the company in a report on Wednesday, February 22nd. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $19.00.

Pediatrix Medical Group Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Featured Articles

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.